NeuroDyne

What NeuroDyne does

NeuroDyne (also referenced as NeuroDyn) is a privately held, for-profit medical technology company developing technology for the diagnosis and treatment of neurological diseases. Founded in 2005 and headquartered in Germantown, United States, the company operates with a very small team of 1-10 employees, consistent with an early-stage R&D-oriented venture. The company has secured a total of approximately $325,648 in disclosed funding across two events: a $275,648 award from the National Science Foundation in February 2021, and a $50,000 investment from the ZeroTo510 medical device accelerator in September 2022. There are no disclosed products, services, pricing models, customer segments, management team members, or partnership details in the available data, and the company's primary web domain (neurodyne.us) currently displays a default cPanel hosting error page rather than active corporate content.

The business model, go-to-market motion, and revenue mechanics cannot be characterized from the input: there is no evidence of commercial sales, contract structures, or pricing models. The funding mix — non-dilutive NSF research funding combined with a small accelerator check — is consistent with a pre-commercial or research-stage profile in which capital is being directed toward technical validation rather than market deployment. The 17-year operating history against a small funding footprint and minimal headcount suggests the venture has operated at low burn, likely on grants and founder resources, without reaching a scaled commercial phase. As of the available data, there are no signals of recent product launches, partnerships, regulatory milestones, or customer wins that would indicate a transition into commercial operations.

Name

NeuroDyne

Website

https://neurodyne.us

Company type

Private

Founded year

2005

Headcount range

1–10 employees

Short description

NeuroDyne is a privately held US medical technology company, founded in 2005 and based in Germantown, that develops technology for the diagnosis and treatment of neurological diseases; the firm operates with 1-10 employees and has disclosed no commercial products or revenue.

Ownership category

akta.pro rank

Product category

Neurological Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

akta.pro secondary industries

General Neurology (HLAKAIAA), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

Keywords

• Neurological medical devices
• Neurodiagnostic equipment
• Neurostimulation technology
• Neurology treatment devices
• Brain monitoring systems

Headquarters

HQ city

Germantown

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations

Core offering

NeuroDyne develops medical technology focused on the diagnosis and treatment of neurological diseases. The company operates as a small, privately held medical device developer based in Germantown, United States, with a workforce of 1–10 employees. Specific product names, technical specifications, and detailed commercial offerings are not disclosed in the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights3 records

Broad incumbents

• Natus Medical: Established neurology-focused medical device company offering neurodiagnostic, neurocritical care, and neurosurgery products. Directly comparable to NeuroDyne as a neurology medical technology developer, though at vastly greater scale.

Emerging players

• Wave Neuroscience: Neurotechnology company developing diagnostics and personalized neurostimulation for brain injuries and neurological conditions. Comparable to NeuroDyne as an early-stage neurology diagnostic/therapeutic developer.
• Cumulus Neuroscience: Early-stage neuroscience technology company building a platform for neurology clinical trials and disease monitoring. Comparable to NeuroDyne as a small neurology diagnostics developer.
• Rogue Research: Privately held Canadian company developing MRI-compatible EEG systems for neuroscience and clinical neurology. Comparable small-scale neurodiagnostic device developer.
• BrainScope: Medical technology company developing AI-powered brain injury assessment devices using EEG. Comparable to NeuroDyne as a small neurology-focused diagnostic technology firm.

Direct peers

• Cadwell Industries: Privately held medical device company specializing in neurodiagnostic (EEG/EMG/IONM) and sleep medicine equipment. A direct comparable as a mid-sized neurodiagnostic device maker.
• NeuroPace: Developer of the RNS System, a neurostimulation device for epilepsy. Comparable to NeuroDyne as a company commercializing implantable neurotechnology for neurological disease treatment.
• electroCore: Commercial-stage bioelectronic medicine company with non-invasive vagus nerve stimulation therapies for neurological conditions. Comparable in therapeutic neurology device focus.
• ANT Neuro: Specializes in high-performance EEG, MEG, and neuromodulation products for clinical and research neurology. Comparable as a focused neurodiagnostic and neurotechnology device maker.
• Compumedics: Designs and manufactures diagnostic devices for sleep, neurology, and brain research. Closely aligned with NeuroDyne's stated focus on neurological disease diagnosis.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroDyne